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Abstract  
Background-The widespread use of brain imaging has led to increased recognition of subclinical 
brain abnormalities, including white matter hyperintensities (WMH) and silent brain infarctions 
(SBI), which have a vascular origin, and have been associated to a high risk of stroke, disability and 
dementia. Carotid atherosclerosis (CA) may be causative in the development of WMH, SBI and 
eventually brain atrophy. Aim of the present systematic review and meta-analysis was to assess the 
existing evidence linking CA to WMH, SBI and brain atrophy.  
Methods-The relation between CA and WMH, SBI and brain atrophy was investigated through the 
systematic search of online databases up to September 2015 and manual searching of references and 
related citations. Pooled estimates were calculated by random-effects model, using restricted 
maximum likelihood method with inverse variance weighting method.  
Results-Of the 3536 records identified, fifteen were included in the systematic review and 9 were 
found to be eligible for the meta-analysis. CA was significantly associated with the presence of 
WMH (Odds Ratio, OR 1.42, confidence interval, CI 1.22-1.66, p<0.0001) and of SBI (OR 1.89, CI 
1.46-2.45, p<0.0001). No meta-analysis could be performed for the relation between CA and brain 
atrophy due to the lack of suitable studies.  
Conclusions-CA was found to be associated to WMH and SBI. While no causative association can 
be inferred from the available data, the presence of carotid plaque may be considered a significant 
risk factor for subclinical cerebral damage. 
 
 
Keywords: Carotid Atherosclerosis, Leukoaraiosis, Silent Brain Infarction, Brain Atrophy, Meta-
Analysis. 
Abbreviations: CA = carotid atherosclerosis; WMH = white matter hyperintensities; SBI = silent 
brain infarctions; OR = odds ratio; CI = confidence interval; MRI = magnetic resonance imaging; 
US = ultrasound; FLAIR = fluid attenuation inversion recovery; IMT = intima-media thickness. 
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1. Introduction 
Asymptomatic carotid stenosis is common in the general population, with prevalence estimates 
being as high as 6% in elderly men and 4.4% in elderly women,[1] while presence of carotid artery 
plaque may be even higher, reaching up to 40% of free living subjects.[2] The widespread use of  
brain magnetic resonance imaging (MRI) has enabled an increased recognition, especially in elderly 
subjects, of cerebral alterations in apparently healthy individuals. A causative role for carotid 
atherosclerosis, however, cannot, to date, be ruled out. MRI detected alterations include white 
matter hyperintensities (WMH), defined as patchy areas of signal hyperintensity on T2-weighted 
and/or fluid attenuated inversion recovery (FLAIR) sequences,[3, 4] and silent brain infarctions 
(SBI), i.e., focal areas of at least 3 mm in diameter showing high signal intensity on T2-
weighted/FLAIR images and low intensity on T1-weighted images, in the absence of corresponding 
neurological signs and symptoms and with no clinical history of stroke.[5, 6] WMH and SBI are not 
innocuous, since they have been  associated with brain atrophy[7] and confer a significant risk of 
incident stroke[8], mood and gait disturbances[9], cognitive decline and dementia[8, 9]. As a 
consequence, they could be considered as markers of “brain frailty”.[10] Both types of lesions are 
thought to have a vascular origin,[6, 9] but their precise etiology remains controversial. Local 
microvascular alterations, embolic occlusion of arterioles or chronic cerebral hypoperfusion have all 
been implicated.[6, 11] Advanced age, cardiovascular risk factors, in particular hypertension, atrial 
fibrillation and patent foramen ovale have been associated with WMH and SBI.[6, 12-17] Carotid 
atherosclerosis, as a source of microemboli [18] or by causing ischemia in case of flow limiting 
stenosis, may contribute to WMH and SBI, and ultimately to brain atrophy.[19] The aim of the 
present systematic review and meta-analysis was to investigate the association between the presence 
of carotid atherosclerotic plaques and WMH, SBI or brain atrophy in the general population, largely 
including asymptomatic subjects. 
2. Methods 
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The present study was conducted following the Preferred Reporting Items for Systematic reviews 
and Meta-Analysis (PRISMA) statement[20] guidelines for its design, implementation, analysis and 
reporting. 
2.1 Search strategy 
We searched for studies assessing the relation between carotid atherosclerosis and WMH, SBI or 
brain atrophy detected with brain MRI. Specific inclusion criteria were: MRI field strength of at 
least 1.0 Tesla, assessment of WMHs on T2-weighted or FLAIR images and definition of SBI as 
focal lesions of at least 3 mm in diameter that appeared hyperintense on T2-weighted or FLAIR 
images and hypointense on T1-weighted images, with no associated neurological symptoms, in 
compliance with recently defined neuroimaging standards.[4] In the absence of a consensus on how 
to assess brain WMH involvement,[4, 21] we did not apply restrictions on the methods used. 
Similarly, no restriction was applied for brain atrophy evaluation method. We included only studies 
providing imaging evidence of carotid artery plaque independently from the modality used, 
including ultrasound (US), digital subtraction angiography, computed tomography angiography or 
magnetic resonance angiography. Studies concerned with the association between carotid intima-
media thickness (IMT) and WMH, SBI or cerebral atrophy were excluded, since IMT, while 
generally considered an early stage of atherosclerotic disease, appears to be biologically distinct 
from carotid atherosclerosis, and its relation to carotid plaques is incompletely understood.[22] 
Studies focusing selectively on stroke patients were excluded to avoid the confounding effect of the 
expected high ischemic burden in these subjects. Since recent evidence suggests that periventricular 
and deep WMH are to be considered as part of a continuous pathology,[3] we excluded those 
studies selectively reporting on either of the two. Finally, we considered an article regarding brain 
atrophy suitable for meta-analysis if it provided mean and standard deviation values of standardized 
total brain volumes both in patients with carotid atherosclerosis and healthy controls. 
Studies reporting the odds ratio (OR) of patients with carotid atherosclerosis for extensive WMH or 
for the presence of SBI were included in the quantitative synthesis. If the study reported both 
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adjusted and unadjusted ORs, we included in the analysis the value adjusted for age and sex, and, if 
available, cardiovascular risk factors. If no OR was available, the article was still included if the OR 
could be manually calculated from the data reported.  
Searches were performed of literature published through September the 30
th
, 2015 using MEDLINE 
and Embase. Additional records were identified on the grey literature database OpenSIGLE, related 
article feature on PubMed and hand searching of reference lists.  
2.2 Data extraction 
Data concerning the imaging technique used to assess the presence of carotid artery plaque, MRI 
field strength, total number and mean age of participants and the proportion of participants with 
history of cerebrovascular disease were collected from each study. For studies on WMH or SBI, 
contingency tables and ORs were extracted. For studies on brain volume, mean and standard 
deviation of standardized total brain volumes were extracted. 
2.3 Statistical Analysis 
Continuous variables are reported as mean (standard deviation) or median (1
st
-3
rd
 quartile). 
Categorical variables are expressed as percentages. The summary effect size was calculated with the 
random-effect models, using restricted maximum likelihood method with inverse variance 
weighting. Between-study heterogeneity was assessed with Q test and I
2
. Potential publication bias 
was assessed by inspecting a funnel plot of effect sizes versus standard errors,[23] and using rank 
correlation test.[24] A meta-analysis was carried out if at least three studies were available for the 
same outcome. All analyses were performed using the metafor package in R.[25] Associations with 
p<0.05 were considered significant. 
3. Results 
3.1 Articles selection 
The search strategy for Embase is shown in Table 1. For other databases, we applied the same 
strategy with variations based on database structure. Of the 3536 articles identified, 3426 records 
were excluded upon title screening. Abstracts of the remaining 110 records were reviewed, which 
6 
 
led to the exclusion of further 42 articles. Full text was evaluated in 68 articles, and 15 were found 
to match our inclusion and exclusion criteria. Of those, 9 were found suitable for meta-analysis. 
Figure 1 summarizes articles’ selection process.  
3.2 Carotid atherosclerosis and WMH 
Ten population-based studies explored the relation between carotid atherosclerosis and WMH [26-
35]. Of those, six, comprising 5306 subjects, fulfilled the criteria for inclusion in the meta-
analysis.[26-31] Table 2 reports data extracted from these studies. Combining all studies, the pooled 
OR for WMH in patients suffering from carotid atherosclerosis was 1.42 (95% confidence interval 
[CI]: 1.22-1.66, p<0.0001), as shown in Figure 2. No evidence of significant heterogeneity was 
present (Q-test p=0.38; I
2
=0.0%). Visual inspection of the funnel plot (Supplementary Figure 1) 
showed some potential for publication bias, despite a nonsignificant rank correlation test (p=0.47). 
In particular, the study by Fazekas et al. [26] appeared as an outlier in terms of sample size and OR. 
However, the exclusion of this study led to marginal changes in the results, yielding a pooled OR of 
1.40 (95% CI: 1.20-1.63, p<0.0001; Q-test p=0.58; I
2
=0.0%).  
Four additional studies were identified through the systematic search, which could not be included 
in the quantitative synthesis.[32-35] Table 3 summarizes the main findings and reasons for 
exclusion from the meta-analysis. Manolio et al. investigated the association between carotid 
atherosclerosis and the extent of cerebral WMH involvement assessed using a visual scoring system 
in a cohort of 3502 subjects older than 65 years of age.[32] These Authors report a significant 
association between carotid atherosclerosis and the severity of white matter changes that was 
stronger with increasing stenosis severity and remained significant after adjustment for age and 
sex.[32]  
De Leeuw et al. described the relation between the number of atherosclerotic plaques in the carotid 
arteries bilaterally and brain WMH, assessed semi-quantitatively, in a cohort of 1077 individuals 
aged 60 to 90 years.[35] They found a significant association between the number of plaques and 
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the severity of WMH in the periventricular white matter, but not in the subcortical region. Such an 
association remained significant after adjustment for hypertension.[35]  
Shrestha et al. explored the association between the number of carotid plaques and carotid plaque 
score, i.e., the sum of the heights of all the plaques detected bilaterally using ultrasound, and the 
extent of WMH assessed by Fazekas score in a cohort of 179 subjects, with a mean age of 66 
years.[34] At multivariable regression, plaque score was independently associated to the severity of 
WMH both in periventricular and deep white matter.[34]  
Finally, Landi et al. assessed the association between carotid atherosclerosis and total WMH 
volume in a cohort of 94 subjects with a mean age of 71 years.[33] At multivariable analysis, they 
found a significant association between age and WMH, but not between carotid stenosis and 
WMH.[33]  
A single, prospective study reported an increased risk (OR=1.76) for severe WMH at 4 years of 
follow up in patients with carotid atherosclerosis.[28] 
3.3 Carotid atherosclerosis and SBI 
Seven studies examined the relationship between carotid atherosclerosis and the presence of SBI at 
brain MRI.[29, 30, 32, 36-39]. Two[29, 32] referred to subgroups of the population of larger 
studies,[36] and [39] respectively, thus, in order to avoid duplications, only the latter were included 
in the present analysis. Four studies, including 3586 participants, fulfilled the criteria for the 
inclusion in the meta-analysis[30, 36-38] (Table 4). They demonstrate a significant association 
between carotid atherosclerosis and the presence of SBI, with a pooled OR of 1.89 (95% CI: 1.46-
2.45, p<0.0001), as shown in Figure 3. 
No evidence of significant heterogeneity was detected (Q-test p=0.23, I
2
=15.5%). The study by 
Giele et al. [38] was identified as a potential source of bias, since the definition of carotid 
atherosclerosis markedly differed from other studies (i.e., presence of a stenosis ≥70% in the work 
by Giele et al. [38], imaging evidence of carotid plaques in all other studies). After the exclusion of 
this study from the analysis, a small increase in effect size was observed, with a pooled OR of 1.94 
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(95% CI: 1.45-2.60, p<0.0001; Q-test p=0.15, I
2
=35.3%). Visual inspection of the funnel plot 
(Supplementary Figure 2) was not suggestive of publication bias, as was rank correlation test (p=1).  
One further study, not suitable for the meta-analysis, was identified through the search.[39] In 
particular, at multivariable analysis, Longstreth et al. described a significant association between 
SBI and  ipsilateral carotid plaque with a stenosis of at least 50% in 3244 subjects aged 65 years or 
more.[39] 
3.4 Carotid atherosclerosis and brain atrophy 
Only three studies assessing the relationship between carotid atherosclerosis and brain volume were 
identified,[29, 32, 40] none of which fulfilled the criteria for inclusion in the meta-analysis. Romero 
et al. observed a highly significant association between the presence of a carotid plaque determining 
a stenosis ≥25% and lower total brain volume to total cranial volume ratio in 1971 subjects.[29] 
Manolio et al. described an association between sulcal widening, bifrontal distance and ventricular 
size, all MRI markers of brain atrophy, and the presence of carotid atherosclerosis in a population of 
3502 elderly subjects.[32] The association remained significant after adjustment for age, sex, 
aspirin use and hypertension. Finally, Muller et al. reported an association between carotid 
atherosclerosis, with a stenosis of at least 50% in diameter, and lower total brain and cortical gray 
matter volume, normalized for intracranial volume, in a population-based cohort of 1232 
subjects.[40] Interestingly, follow up data at 4 years were available for 663 participants, and 
showed a significant association between severe, i.e., stenosis ≥70%, or bilateral carotid 
atherosclerosis and progression of global, cortical and subcortical atrophy.[40] 
4. Discussion 
The main finding of the present systematic review and meta-analysis was the demonstration of a 
significant association between carotid atherosclerosis and a higher risk of both WMH and SBI. The 
association appears to be particularly robust, since it derives mainly through the analysis of either 
multivariate OR or from directly calculated OR, which are believed to reduce spurious associations 
due to reporting bias. Secondarily, we found records concerning the relation between carotid 
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atherosclerosis and brain volumes: surprisingly few studies were identified, [29, 32, 40], but all 
appeared to suggest an association between carotid plaque and brain atrophy.  
As the use of brain MRI has become increasingly widespread, clinicians often have to cope with the 
incidental finding of silent cerebral alterations, particularly in patients with asymptomatic carotid 
artery plaques. WMH and SBI are frequently discovered in healthy subjects, and their prevalence 
depends on age.[41-43] These lesions were shown to associate with brain atrophy, a marker of 
accumulating cerebral damage.[7, 44] Both WMH and SBI appear to have a vascular pathogenesis 
[6, 9, 45] and both are strongly associated with cardiovascular risk factors and atrial fibrillation.[6, 
12, 13] However, the precise etiology is yet to be defined. Indeed, local vascular degenerative 
processes leading to hypoperfusion or acute ischemia with tissue necrosis,[9] distal embolization 
from the heart[13] or from a large vessel,[46] or chronic reduction in cerebral perfusion, have all 
been implicated.[19, 47] Carotid atherosclerosis may thus contribute to the pathogenesis of both 
WMH and SBI as a source of microemboli [48] or through the reduction of cerebral blood flow.[49]  
While some of the studies eligible for the present systematic review and meta-analysis reported an 
increasing cerebral involvement proportional to the degree of the carotid stenosis,[29, 32] many of 
the studies did not report stenosis severity.[26-28, 30, 31] In others, patients with hemodynamically 
significant stenosis, i.e., ≥50%, were absent or under-represented.[36, 37] These data support a 
potential etiologic role for carotid atherosclerosis in the development of WMH and SBI, but 
possibly suggest that the presence of a flow limiting stenosis is not required, making the chronic 
ischemia hypothesis less likely. Furthermore, some reports associated the presence of vulnerability 
features within the plaque to a higher burden of silent ischemic brain damage, suggesting a direct 
role for atherothrombosis and subsequent distal embolization.[29, 50, 51] A recent meta-analysis 
showed a significant association between atrial fibrillation and presence of SBI, with a pooled OR 
of 2.62, which supports an embolic origin for these lesions.[52] A direct causative role for carotid 
atherosclerosis with an embolic mechanism would imply a higher burden of silent ischemic lesions 
ipsilateral to the site of carotid artery disease. Research in this field, however, yielded mixed 
10 
 
results.[53-55] Indeed, the association may be accounted for by the risk factors shared by carotid 
atherosclerosis, WMH and SBI, including age, hypertension, dyslipidemia, smoking and 
diabetes.[9, 12] Carotid atherosclerosis may be considered a marker of higher ischemic 
vulnerability of the brain. This may allow the clinician to identify subjects at risk of stroke and 
dementia, and prompt an aggressive correction of cardiovascular risk factors, eventually including 
the initiation of treatment which were shown to effectively slow the progression of cerebral 
ischemic damage, including antiplatelet medications, as aspirin[56] or cilostazol[57] and lipid 
lowering medications such as statins.[58] 
5. Conclusions 
Carotid atherosclerosis appears to be strongly associated to the presence of WMH (OR=1.42, 
p<0.0001) and SBI (OR=1.89, p<0.0001). The few available studies concerning the relation 
between carotid atherosclerosis and brain volumes suggest that carotid plaques and cerebral atrophy 
may be associated. While any speculation about the causative role of carotid atherosclerosis for 
WMH, SBI and subsequently brain atrophy cannot be made from the available literature, carotid 
atherosclerosis can be proposed as a marker for susceptibility to ischemic cerebral damage.  
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Figures 
Figure 1. Study selection flow diagram 
Figure 2. Meta-analysis of the studies evaluating the association between carotid 
atherosclerosis and white matter hyperintensities. OR: odds ratio; CI: confidence interval. 
Figure 3. Meta-analysis of the studies evaluating the association between carotid 
atherosclerosis and silent brain infarctions. OR: odds ratio; CI: confidence interval. 
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Tables 
Table 1. Search strategy for Embase. For other databases, i.e. MEDLINE and OpenSIGLE, we 
applied variations based on database structure. 
#1  ‘carotid artery disease’/exp 
#2 ‘white matter lesion’/exp 
#3 ‘leukoaraiosis’/exp 
#4 white AND matter AND hyperintensit* 
#5 2# OR #3 OR 4# 
#6 ‘brain atrophy’/exp 
#7 silent OR occult 
#8 ‘cerebrovascular accident’/exp 
#9 #7 AND #8 
16 
 
#10 ‘lacunar stroke’/exp 
#11 #9 OR #10 
#12 #5 OR #6 OR #11  
#13 #1 AND #12 
#14 Filter #13 for “English and Humans” 
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Table 2. Data extracted from the studies evaluating the relation between carotid atherosclerosis and white matter hyperintensities.  
Author Year CA 
Imaging 
MRI N CA and 
WMH 
Reporte
d OR 
Calculat
ed OR 
Age 
(years) 
Proport
ion of 
sympto
matic 
subjects 
(%) 
Fazekas 1988 US 1.5T 52 19 NA 3.56 58 0 
Bots 1993 US 1.5T 111 8 NA 1.04 74 0 
Pico 2002 US 1.0T 640 46 1.35† 1.56 62 0 
Romero 2009 US 1.0T 1971 NA 1.76‡ - 58 NA§ 
Yoshida 2012 US 1.5T 790 90 NA 1.25 61 0 
Brisset 2013 US 1.5T 1742 NA 1.37† - 72 NA|| 
 Proportion of symptomatic subjects reports the number of subjects with symptomatic cerebrovascular 
disease. MRI = magnetic resonance imaging; CA = carotid atherosclerosis; WMH = white matter 
hyperintensities; OR = odds ratio; US = ultrasound. †Adjusted for age, sex and cardiovascular risk 
factors; ‡Adjusted for age and sex; §Overall manifest cardiovascular disease (including cerebrovascular 
disease, coronary artery disease, heart failure and peripheral artery disease) 7.5%; ||Overall manifest 
cardiovascular disease (including cerebrovascular disease, coronary artery disease, heart failure and 
peripheral artery disease) 6%. 
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Table 3. Studies concerned with the relation between carotid atherosclerosis and white matter 
hyperintensities not included in the meta-analysis. 
Author Year n Main findings Reasons for exclusion 
Manolio 1999 3502 WMH severity assessed 
with an Authors’ 
defined visual scoring 
system increased with 
increasing stenosis 
severity. The association 
remained significant 
after age and sex 
adjustement. 
Both WMH and CA 
treated continuously. 
No variances reported. 
OR was not reported or 
calculable. 
DeLeeuw 2001 1077 Significant association 
between number of 
plaques in the carotid 
arteries and a 
semiquantitative 
measure of WMH 
severity in the 
periventricular, but not 
in the subcortical, white 
matter. 
Not reported the 
number of subject 
without CA. WMH 
treated as a continuous 
variable. Distinction 
between periventricular 
and subcortical WMH. 
Shresta 2007 179 Plaque score, i.e. the 
sum of the thickness of 
all plaques identified 
bilaterally in the carotid 
arteries, significantly 
correlated with WMH 
assessed with Fazekas 
score. 
CA and WMH treated 
as continuous variables. 
Insufficient data for OR 
calculation. 
Landi 2015 94 No association between 
the degree of stenosis 
and cerebral WMH in a 
multivariate analysis 
including age and 
cardiovascular risk 
factors 
Number of subjects 
without CA was not 
reported. Insufficient 
data to calculate OR. 
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Table 4. Data extracted from the studies evaluating the relation between carotid atherosclerosis and silent brain infarctions.  
Author Yea
r 
CA 
Imagi
ng 
MR
I 
N CA and 
SBI 
Reported 
OR 
Calculated 
OR 
Age 
(years) 
Proportion of 
symptomatic 
subjects (%) 
Giele 2003 US 1.5T 308 1 NA 0.84 58 0 
Inoue 2006 US 1.5T 448 19 NA 3.28 51 0 
Das† 2008 US 1.0T 2040 NA 1.62‡ . 58 0 
Yoshid
a 
2009 US 1.5T 790 93 NA 1.84 61 0 
 Proportion of symptomatic subjects reports the number of subjects with symptomatic cerebrovascular 
disease. MRI = magnetic resonance imaging; CA = carotid atherosclerosis; SBI = silent brain 
infarction; OR = odds ratio; US = ultrasound. †Presence of plaque defined for carotid stenosis of at 
least 25%; ‡Adjusted for age and sex. 
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Online Figures Captions 
eFigure1. Funnel Plot for the meta-analysis on the relation between carotid atherosclerosis 
and white matter hyperintensities. The visual inspection of the Funnel Plot is suggestive for the 
presence of small study effect, i.e. the study with the smallest sample size appears to be the one 
with the largest effect size (bottom right), despite a non significant rank correlation test (p=0.47). 
eFigure2. Funnel Plot for the meta-analysis on the relation between carotid atherosclerosis 
and silent brain infarctions. The visual inspection of the funnel plot does not suggest the presence 
of small study effect, which is supported by a non significant rank correlation test (p=1). 
 
